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Background: Advances in the next generation sequencing technology has accelerated the pace of individualized
medicine (IM), which aims to incorporate genetic/genomic information into medicine. One immediate need in
interpreting sequencing data is the assembly of information about genetic variants and their corresponding
associations with other entities (e.g., diseases or medications). Even with dedicated effort to capture such information
in biological databases, much of this information remains ‘locked’ in the unstructured text of biomedical publications.
There is a substantial lag between the publication and the subsequent abstraction of such information into
databases. Multiple text mining systems have been developed, but most of them focus on the sentence level
association extraction with performance evaluation based on gold standard text annotations specifically prepared
for text mining systems.
Results: We developed and evaluated a text mining system, MutD, which extracts protein mutation-disease
associations from MEDLINE abstracts by incorporating discourse level analysis, using a benchmark data set extracted
from curated database records. MutD achieves an F-measure of 64.3 % for reconstructing protein mutation disease
associations in curated database records. Discourse level analysis component of MutD contributed to a gain of more
than 10 % in F-measure when compared against the sentence level association extraction. Our error analysis indicates
that 23 of the 64 precision errors are true associations that were not captured by database curators and 68 of the 113
recall errors are caused by the absence of associated disease entities in the abstract. After adjusting for the defects in
the curated database, the revised F-measure of MutD in association detection reaches 81.5 %.
Conclusions: Our quantitative analysis reveals that MutD can effectively extract protein mutation disease associations
when benchmarking based on curated database records. The analysis also demonstrates that incorporating discourse
level analysis significantly improved the performance of extracting the protein-mutation-disease association. Future
work includes the extension of MutD for full text articles.
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(http://creativecommons.org/publicdomain/zeroabout genetic variants especially mutations in coding re-
gions (i.e., protein mutations) and their associations with
diseases. Such information has been catalogued in mul-
tiple biomedical databases such as ClinVar [2], OMIM
[3], or UniProtKB [4]. Peterson et al., 2013 [5] list nearly
21 resources containing protein mutation disease associa-
tions. Even with dedicated effort in capturing such infor-
mation in biomedical databases, much of this information
still remains ‘locked’ in the unstructured text of biomedical
publications. Additionally, the interpretation of “novel”s article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver
/1.0/) applies to the data made available in this article, unless otherwise stated.
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ants may not be “novel” which are already published in the
literature. For example, the latest evidence indicates that
PSEN1, p.E318G variant is associated with the develop-
ment of early-onset of Alzheimer’s disease (AD) for
APOE-ε4 carriers [6–10]. OMIM has not been updated
with this clinically relevant finding. Instead OMIM
states “the E318G change is a polymorphism with un-
certain clinical significance” based on the 2005 publica-
tion [11]. Similarly, many of these databases including
UniProtKB and NCBI ClinVar fail to report the signifi-
cance of the PSEN1, p.E318G variant with early onset
AD. Thus, the development of text mining approaches
to accelerate the process of assembling IM knowledge
in published literature is necessary.
Text mining techniques can be potentially applied to
mitigate such information lag [12]. Multiple text mining
systems have been developed for extracting mutation
events (e.g., Mutation-Finder [13] and EMU [14], tmVAR
[15]); as well as relation extraction to associate mutation
events to other entities such as proteins, (e.g., MEMA
[16], MuteXt [17], MuGeX [18] and Mutation-GraB [19]),
genes (e.g., Polysearch [20]), diseases (e.g., SNPShot [21]),
and drugs (e.g., SNPShot). Most of these systems use regu-
lar expressions to detect mutation mentions form bio-
medical text but associations between mutations and
other entities are based on simple co-occurrence informa-
tion. For example, SNPShot extracts various binary rela-
tions between genes, variants, drugs, diseases and drug
reactions using simple co-occurrence statistics and
normalize entities to databases such as EntrezGene [22],
PharmGKB [23], or PubChem [24].
MEMA [16] and MuteXt [17] applied word distance
metric to retain the right protein-mutation pairs ex-
tracted based on sentence co-occurrence.; Mutation-
GraB [19] applied weighted graph-based traversal to re-
solve ambiguity and retain only the protein-mutation
pairs that have the shortest path between them. On the
other hand, Doughty et al. [14] have proposed the use of
sequence information to validate the associations. More
sophisticated approaches based on grammar parsing have
been extensively employed for relation extraction in the
NLP shared task. For example, Open Mutation Miner [25]
attempts to extract the impact of mutation on protein
function and its properties such as kinetics and stability
using a rule-based approach based on shallow parsing.
Some recent studies on automatic linking of protein mu-
tations and diseases consider advanced linguistic features
such as dependency parse graphs [26, 27].
Rationale
Most of the previous studies discussed above [17, 18,20,
21] have estimated their text mining performance against
text-based gold standard annotations and not againsthuman curated gold standard annotations in the databases.
While the text based gold standard annotations consider
only the information given in the document for annota-
tion, database annotations may infer information from
multiple documents relevant to the task for curation be-
sides the curator’s domain knowledge. Hence evaluating
text mining systems against biomedical text gold stan-
dards does not estimate the “practical utility” of these sys-
tems for database curation task. In this section, we briefly
discuss the rationale behind this work and the issues that
we attempt to address in the current study.
Biomedical database curation workflow and the role of text
mining
Database curation broadly involves the following steps
[28] generally followed by human curators with the re-
quired domain knowledge.
Step 1 Problem and curation guideline definition -
Define the problem domain selected for curation
and its guidelines,
Step 2 Collection of literature pool – Collect the seed
literature pool through appropriate choice of search
terms using information retrieval engines such
as PubMed.
Step 3 Retrieval of relevant article – Retrieve the
relevant abstracts/articles from the literature tool
using API such as Entrez e-utils in PubMed.
Step 4 Identification of relevant evidence sentences –
Manually read the literature and identify the
evidence sentences in the individual abstract/article
based on their relevance to the target problem
considered for curation.
Step 5 Identification of entities – Identify and mark
up the entity mentions in the text.
Step 6 Normalization of entity mentions to database
concepts - Normalize the entity mentions in the text
to ontological concepts or database identifiers.
Step 7 Identification of relations between entities -
Extract the relations between the entity mentions
both within and across sentences.
Step 8 Store the abstracted concepts and relation in
the database – This is the final step that involves
transformation of information in natural language
to structured representation in flat file such as XML
or in a relational database.
The major bottleneck in the database curation work-
flow is the manual effort required in each of these steps.
Text mining systems have been used to assist the cura-
tors to accelerate the curation workflow, mainly for the
initial steps from 1 to 4. The performance of the existing
tools is unsatisfactory for the latter steps from 5 to 7.
Steps 5–7 involve normalization and inferences, which
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uments, and domain knowledge sources such as bio-
medical ontologies.
Figure 1 illustrates two major inference challenges: lin-
guistic inference and expert inference using two sen-
tences from an abstract (PMID-8112750) describing
the association between a point mutation “Asp399Asn”
of “glucocerebrosidase gene” and “Gaucher’s disease”.
While the first sentence has the mentions of gene/pro-
tein and disease, it is the second sentence that provides
the site of mutation information. Linguistic inference is
required to connect the two pieces of information men-
tioned in different sentences to infer the role of muta-
tion in a disease. Current text mining tools fall short of
making such linguistic inferences. Prior to relation ex-
traction, normalization of the entities to the ontological/
database definitions requires inference predominantly
based on the background knowledge and the linguistic
inference drawn from the description in the current text.
The state of the art of entity normalization, particularly
the gene and disease has been steadily increasing to ac-
ceptable levels thanks to the organization of series of
shared tasks such as BioCreative [29, 30]. However,
normalization of the mutation site mentions in the text
to the sequence in biomedical databases has been a chal-
lenge. It requires inference by the curation expert to
judge whether the mutation residue position mentioned
in the text accounts for the signal peptide region. In the
example shown in Figure 1 the position of mutation Asp
to Asn is mentioned as “399” in the text. However, the
gold standard annotation in UniProtKB mentions theFig. 1 Role of human inference in database curationsite of mutation to be “438”. The curator has utilized his/
her biological knowledge to infer that the sequence re-
ported in the paper does not include signal peptide region
(a total of 39 residues). The length of signal peptide re-
gion, 39 is added to the position mentioned in the text,
399, which gives the final position, 438, mentioned in the
gold standard. Such expert inference capability is beyond
any text mining system.
Leveraging the existing knowledgebase annotations for
text mining often referred to as weakly supervised/dis-
tant supervision learning has been on the rise in other
domains [31, 32]. Such distant supervision approaches
[33, 34] were explored in a limited context for learning
patterns relating protein and its sites mentioned in a sin-
gle sentence using multiple database annotations such as
UniProtKB and PDB.
In this paper, we present a text mining system, MutD,
which extracts protein mutation-disease associations
from MEDLINE abstracts by incorporating discourse
level analysis. We evaluated the performance of MutD
to extract mutation disease relations against human cu-
rated annotations in UniProtKB as the gold standard. In
the following sections, we describe tools and resources,




The system developed for this study (MutD) was imple-
mented under Apache Unstructured Information Man-
agement Architecture (UIMA) [35]. We used the Unified
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[36], BioThesaurus (V2.1) [37], Comparative Toxicoge-
nomics Database (CTD)’s [38], and merged disease vo-
cabulary (MEDIC) [39] ontology as terminology sources
for recognizing diseases and proteins mentioned in the
text. BioTagger-GM [40] is used for dictionary lookup.
We used Stanford parser [41] to generate the depend-
ency parse representation from individual sentences.
For entity recognition and normalization, in addition
to customized BioTagger-GM [40] we also used exist-
ing systems, MutationFinder [13], PubTator [42] and
GeNo [43]. We used UniProtKB to extract curated
ternary relations to form a gold standard data set to
develop, refine and evaluate the system. The following
provides a brief background of each of resources and
systems.UIMA
Apache UIMA [35], is a data-driven architecture where
components communicate with each other through
Common Analysis System (CAS) containing annota-
tions. Each annotation is an instance of a given type de-
fined by a specified hierarchical type system.UniprotKB
UniProtKB [4] is a protein database partially curated by
experts, consisting of two sections: SwissProt where en-
tries have been manually annotated and TrEMBL where
entries are automatically annotated. The manual anno-
tation process of an entry in UniProtKB involves de-
tailed analysis of the protein sequence with the
scientific literature being the primary evidence. For this
study, we specifically use the curated information about
mutation and its role in diseases. Only the SwissProt en-
tries are used to automatically generate the gold stand-
ard data set.BioThesaurus
BioThesaurus [37] is a web-based system designed to
map a comprehensive collection of protein and gene
names to protein records in UniProtKB [4]. Currently
covering four million proteins, BioThesaurus consists of
over 6 million names extracted from multiple molecular
biological databases according to the database cross-
references in iProClass [44]. The data is downloadable
from the iProLINK [45].MEDIC
MEDIC is a comprehensive collection of disease names
from two major resources namely MeSH [15, 36] and
OMIM [3]. The OMIM entries are mapped to hierarch-
ical entries in MeSH ontology. This results in not onlythe integration of both these resources but provides a
hierarchical structure to OMIM ontology as well. MEDIC
consists of 9700 unique diseases with close to 67, 000
terms that includes synonyms.
BioTagger-GM
BioTagger-GM [40] is a gene recognition system, which
takes a hybrid approach to recognize gene names. In the
first step, the system combines dictionary lookup with ma-
chine learning to detect gene names. Subsequently heuris-
tics were used to filter false positives. The system finally
performs a voting on the output of all methods, and builds
a consensus among them. The system achieved F-measure
of over 85 % for the gene mention task, and ~78 % for the
gene normalization task. Here gene mention refers to the
detection of the spans of gene names in the text, while
gene normalization refers to associating a specific gene
mention to a unique Entrez gene symbol. BioTagger-
GM is the state of the art system for gene mention and
normalization.
MutationFinder (MF)
MutationFinder [13] is an open-source, high-performance
information extraction system that extracts mentions of
point mutations from free text. MutationFinder applies a
set of approximately 700 regular expressions to identify
mutation mentions in the input text. On blind test data,
the precision of MF is 98.4 % and recall 81.9 %, when
extracting point mutation mentions. We used Muta-
tionFinder version 1.1 for this study, which is imple-
mented in UIMA.
GeNo
GeNo [43] is a gene normalization tool that uses a set of
symbolic and statistical methods by fully relying on
publicly available software and data resources, including
extensive background knowledge based on semantic
profiling. GeNO achieved a F-measure of 86.4 % for the
gene normalization task on the BioCreative-II [29, 30]
test set. GeNO is available as a remotely employable
UIMA Analysis Engine (AE). This AE bundles the gene
mapper with key components like named entity recog-
nition component JNET [46].
PubTator
PubTator [42] is a web-based service from NCBI that
delivers entity annotations such as Gene, Mutation,
Disease, Species and Chemical for PubMed abstracts.
The entities are further normalized to ontological defini-
tions where genes are normalized to Entrez Gene Id, dis-
ease and chemical names are normalized to MeSH ID
and species to NCBI taxonomy. PubTator is an ensemble
of state of the art algorithms for entity detection namely
GenTUKit [47] for detecting gene mentions, GenNorm
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detection and normalization and DNorm [50] for disease
entity mentions and normalization.
System implementation
Figure 2 illustrates the overall system architecture
implemented for this study. The system includes com-
ponents for retrieval of abstracts, sentence detection,
tokenization, lexical normalization, dictionary lookup
for entity normalization, and relation extraction. The
following sections briefly describe the details of each of
the components.
Retrieval
The pipeline starts with the retrieval of PubMed abstracts
for a given query (PMID in the current work) using the
Entrez e-utils web service [51].
Preprocessing
The system includes a series of pre-processing modules
such as sentence splitting and tokenization using OpenNLP
[52]. It also includes a lexical normalization component,
which converts words to a canonical form using the Lex-
ical variant generator (LVG) [53] provided by the National
Library of Medicine (NLM).
Term identification
The term identification component has modules to
recognize protein, point mutations, and disease terms
from PubMed abstracts. We retrieved the entity annota-
tions: protein/gene, mutation and disease for all the
PubMed abstracts considered for this study using the
web service of PubTator [42] through the web serviceFig. 2 System architectureprovided by the tool. The protein/gene, mutation, and
disease from PubTator normalized to Entrez Gene ID,
dbSNP/MEDIC, and MeSH respectively. For this study
we considered only the point mutations (substitutions)
annotated by tmVAR of PubTator. Besides PubTator, we
also used entity recognition for protein from the Entrez/
UniprotKB, applied within a BioTagger-GM [40] frame-
work. For mutations, we also use MutationFinder [13] to
detect protein point mutations from the text. We ran
each of these tools individually and finally retain all the
normalized annotations from the combination of a selec-
tion of state of the art tools such as PubTator, GeNO,
BioTagger-GM, and Mutation-Finder. Wherever there is
disagreement between the entity boundaries we consid-
ered the longest span of the entity.
Detection of abbreviations
Abbreviations are quite often used in biomedical litera-
ture. Entity detection tools may identify abbreviations and
the associated definitions (protein/disease). We use the
Schwartz algorithm [54] to detect abbreviations. If the
long form is identified as an entity, we also assign the
same semantic type and ontology id to the short form
within the scope of the abstract.
Graph traversal in the dependency parse graph
representation
Post entity extraction we simplify the sentences by re-
placing the actual entities in the sentence with the
normalized entities. For example consider the following
sentence from an abstract: “A presenilin 1 mutation
(Ser169Pro) associated with early-onset AD and myo-
clonic seizures”. We replace the actual entity mentions
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retraced in the text. Protein mention such as “presenilin
1” in the above sentence is replaced by its Uniprot ID
(PSN1_HUMAN). Similarly, disease mentions such as
“early onset AD” and “myoclonic seizures” are respect-
ively replaced by MeSH Ids “D000544” and “D004831”.
We replace the mutation mentions with the text “MUT”
followed by an incremental index number as they occur
in the text. If two mutations are identical, they are re-
placed by the same index. For example in the example
sentence, the mention of Ser169Pro is replaced with
MUT0. The original sentence after replacements is sim-
plified to: “A PSN1_HUMAN mutation (MUT0) associ-
ated with D000544 and D004831.” We then process
the simplified sentence through Stanford dependency
parser [41] and obtain the dependency graph, which
captures the dependencies between the words in the
modified sentence. We use the collapsed dependencies
graph representation, which propagates the conjunction
dependencies and collapses the dependencies involving
prepositions. The approach is similar to the one pro-
posed by Coulet et al. 2010 [26]. During the graph tra-
versal, we assume that if the three target entities (i.e.
protein, mutation and disease) share a common node,
they are related to each other. Figure 3 illustrate all the
individual steps in relationship extraction through
graph traversal using an example sentence involving all
the three entities.Extra-Sentential processing
Quite often we do not find all the three entities (i.e.
protein, mutation, and disease) occur in a single sen-
tence. They are often located in different sentences. To
handle such cases we developed methods to associate
entities across multiple sentences. Our approach in-
cludes two steps:Fig. 3 Steps in dependency parse graph traversalLinking dependency graphs from multiple sentences
As the first step towards extracting information from
different sentences, we link dependency graphs across sen-
tences based on entity identifiers. If dependency graphs
from two or more individual sentences share the same
entity, we link the graphs. Consider the following two sen-
tences from an abstract (PMID: 21062920) where the entity
mentions are replaced with database identifiers/symbols.
“Mechanistic insights into C566471 caused by DSC2_HU-
MAN mutations.” and “The two missense mutations
(DSC2_HUMAN MUT5 and MUT6) have been function-
ally characterized …” The dependency parse graph traver-
sal for the first sentence (shown in Figure 4) yields only the
relationship between the disease arrhythmogenic right ven-
tricular cardiomyopathy (MesH: C566471) and the protein
desmocollin-2 (UniProt ID: DSC2_HUMAN). No point
mutation is mentioned within the same sentence. However
in one of the subsequent sentence there is a mention of
the same protein and its two point mutations. The rela-
tion between the two mutations R203C (replaced with
MUT5) and T275M (replaced with MUT6) and the pro-
tein (DSC2_HUMAN) is extracted by the dependency
parse graph traversal as shown in Fig. 4. Since the protein
DSC2_HUMAN is common between the two graphs we
linked these two graphs, which yield a connection between
the three entities yielding two ternary relations namely <
DSC2_HUMAN, R203C, C566471 > and <DSC2_HU-
MAN,T275M, C566471 > .
Linking dependency graphs across sentences using
anaphora and trigger words In scientific discourse, it is
quite common to use anaphora to refer to entities men-
tioned in other portions of the text. In this work, we con-
sider linking dependency parse graphs from multiple
sentences through anaphora resolution. We adapted the
anaphora resolution system that is described in Ravikumar
et al., 2013 [55]. Besides anaphora, we observed a lot of
Fig. 4 Linking dependency graphs on entity identity
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tities that are mentioned in earlier sentences or one of the
subsequent sentences. We treat such trigger words (e.g.
mutation, mutant, variations, variants, mutational, patient,
phenotype) as anaphoric though they may not be consid-
ered anaphora category in strict grammar sense. Figure 5
illustrate how anaphoric references are used to link two
dependency graphs from different sentences.
Post-processing
A few post-processing steps are implemented after
extracting these relations. We replace the modified mu-
tations with the original entities during this step. Then
we separate the three individual components of point
mutations from PubTator namely the wild type residue,
the mutant residue and the position of the residue in the
amino acid sequence. Next, we map the mutant and theFig. 5 Linking dependency graphs based on discourse analysiswild type residue from its single letter or full name no-
tation to its three-letter notation. We also map the dis-
ease MeSH Ids to OMIM Ids through MEDIC ontology
[39] available in CTD [38]. Mapping disease terms to
OMIM is essential as the disease annotation in UniProtKB
is normalized to OMIM entries. For example, the ternary
relation <DSC2_HUMAN, R203C, C566471 > extracted
from the text, will be finally transformed to <DSC2_HU-
MAN, Arg, 203, 275, Cys, 610476 >where DSC2_HU-
MAN is UniProtKB ID, Arg is the wild type residue, 203
represents the residue position, 275 the normalized resi-
due position after accounting for the signal peptide re-
gion, Cys is the mutant residue and 610476 is the
OMIM Id for the disease arrhythmogenic right ventricu-
lar cardiomyopathy. If there is more than one OMIM Id
associated with a MeSH Id, we retain all the OMIM Ids
for that output.
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Figure 6 illustrates the experimental workflow that we
adopted in the study. We first extracted gold standard
instances from curated database records in UniProtKB.
Specifically, we used SwissProt, the manually curated por-
tion in UniProtKB, to extract protein mutation disease as-
sociations that are used as a gold standard.
Figure 7 shows an example illustrating the steps in-
volved in extracting gold standard instances. Specifically,
we extract UniProtKB ID (APC_HUMAN), wild type
(Ala), its position in the sequence (1296), mutant residue
(Val), OMIM ID (155255, i.e., Medulloblastoma) from
the curated portion of UniProtKB (i.e., SwissProt) and
the cited PubMed Id (PMID - 10666372). If the sequence
annotation has signal peptide region, we subtract the
length of the signal peptide from the mutation site pos-
ition, which results in an expanded annotation containing
the adjusted sequence position. If the sequence position is
not mentioned, we retain the original position of the mu-
tation for the adjusted position. As shown in Fig. 7, the
final gold standard annotation is recorded as <APC_HU-
MAN, Ala, 1296, 1296, Val; 155255, 10666372>. Quite
often we observe that the mutation position mentioned in
UniProtKB ID differed with the position mentioned in the
text. This difference is mainly due to the length of the sig-
nal peptide region. In such cases, We adjust the mutation
position by subtracting the length of the signal peptide re-
gion (39 in case of GLCM_HUMAN) from the one men-
tioned in the UniProtKB.Fig. 6 Experimental designSince our focus was on association detection, we
retained only those abstracts with at least one disease
mention, one gene/protein mention and one mutation
mention (tmVAR and MutationFinder). The data set
was then split into two sets namely development (D)
and test (T) sets. We used the development set to de-
velop the MutD system and the test set for blind evalu-
ation. We compared five variations of the system where
the first two systems (S1 and S2) served as the baseline
and the remaining three (S3, S4, and S5) utilized de-
pendency graph traversal.
 S1 uses abstract-level co-occurrence.
 S2 uses sentence-level co-occurrence.
 S3 performs dependency graph traversal of a
single sentence.
 S4 links dependency graphs across multiple
sentences, using entity identifiers.
 S5 links dependency graphs, using entity identifiers,
anaphoric terms, and trigger words.
Evaluation metrics
We report the results in terms of precision, recall
and F-measure where precision is a measure of sys-
tem accuracy, recall its coverage, and F-measure, a
harmonic mean of precision and recall. Let TP, FP,
and FN be the number of correct, incorrect, and missed
associations extracted by the system in comparison with
the gold standard, respectively. The precision, recall,
Fig. 7 Extraction of gold standard from UniProtKB
Table 1 Gold standard relation statistics (Development and test
data set)
S. No Relation Data set Total numbers
1 Protein-Mutation-Disease (PMD) D 631
T 264
2 Protein – Mutation (PM) D 879
T 388
3 Protein-Disease (PD) D 671
T 295
D – Development set; T – Test set
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TP
TPþFP ; ¼ TPTPþFN ; and F−Measure ¼ 2PrecisionRecallPrecisionþRecallð Þ .
Results and discussion
Gold standard data set extracted from UniProtKB
There are 2,613 abstracts in total cited as literature evi-
dence of curated protein mutation disease associations.
Using state-of-the-art entity mention tools, we found 720
abstracts from 497 UniProtKB records with at least one
disease mention, one mutation mention, and one gene/
protein mention. We retrieved the title and abstract of the
PubMed articles cited as evidence in the records using
Batch Entrez (e-utils). The 720 abstracts were divided into
development (576) and testing (144) with a ratio of 80:20.
The development and test data sets contain 631 and 264
gold standard associations respectively.
Table 1 summarizes the ternary and binary relations con-
tained in the development (D) and test (T) data sets. Note
that not all binary relations are part of ternary relations.
For example, there are 40 more protein-disease relations in
the development data set but the underlying association is
not about protein mutation disease information.
System performance
In the task of relation extraction, we have two subtasks.
1) Named entity recognition and 2) Protein-Mutation-
Disease relation extraction. We did not formally evaluate
the named entity recognition and normalization in the
current study due to our choice of considering UniProtKBas the gold standard. Evaluating named entity recognition
and normalization against UniProtKB as Gold standard
has the following limitations. PubMed (PMID) cited as a
reference in UniProtKB against a particular protein often
contain entities mentioned in an abstract. Besides we
considered only those UniProtKB entries, which contain
Protein-Mutation-Disease relation curated in UniProtKB.
PubMed abstracts also contain other entity names, which
may not be the focus of the current paper. Even though
the entity mention detection is correct as per the text,
since the PMID is not found in UniProtKB against those
protein entries, such entities will be considered as inaccur-
ate. Our estimation of Precision, Recall and F-measure
will also not be accurate. For example, the abstract with
PMID-21828135 is cited as a reference in 3 UniProtIDs
(KDM6A_HUMAN, DNM3A_HUMAN, and EZH2_HU-
MAN). However, the abstract contains a sentence “TET2
mutations were present in 49 %, ASXL1 in 43 %, CBL in
Ravikumar et al. BMC Bioinformatics  (2015) 16:185 Page 10 of 1514 %, IDH1/2 in 4 %, KRAS in 7 %, NRAS in 4 %, and
JAK2 V617F in 1 % of patients.” where additional protein
names (in bold) were identified and normalized to respect-
ive UniProtIDs. While they are correct considering the in-
formation in the abstract, they will be wrong since they
are not annotated in UniProtKB. Considering these fac-
tors, we did not perform evaluation for named entity per-
formance and instead chose only the state of the art tools
that are known to perform well in the detection and
normalization of protein, mutation and disease entities in
the text which have performed really well on shared tasks.
Table 2 lists the evaluation results on the development
and test data sets of all the five system variants respect-
ively. The columns under heading PMD in Table 2 refer
to the performance of the ternary relation extraction
among protein, mutation and disease. The performance
metrics of binary relations such as protein-mutation
(under heading PM), mutation-disease (under heading
MD), and protein-disease (under heading PD) relations
are also shown in Table 2. Figure 8 plots the performance
of the ternary relation and Figure 9 intends to bring in-
sights on the performance of individual systems and also
highlight the gaps in their performance.
The abstract level co-occurrence (S1) has the highest
recall, while the sentence level dependency graph traver-
sal (S3) achieved the highest precision for extracting the
ternary association between protein, mutation and dis-
ease. The maximum F-measure (achieved by S5) on the
development and test sets is 66.7 % and 64.3 % respect-
ively, close to 4 % percentage gain in the F-measure than
abstract level co-occurrence (S1). Another interesting ob-
servation is that we found only 36 % of the ternary rela-
tions within a single sentence (S2).
We observed a trend similar to that of ternary relation
extraction in the case of binary relation extraction. WhileTable 2 Evaluation results on development (D) and test (T) data set
Sys Set PMD PM
P R F P R
S1 D 60.0 69.3 64.3 69.2 68.4
T 52.6 72.0 60.8 65.5 71.4
S2 D 76.2 39.0 51.6 82.6 48.1
T 77.3 41.3 53.8 76.3 43.0
S3 D 77.1 36.3 49.7 84.4 45.6
T 78.7 36.4 49.7 79.1 38.9
S4 D 76.4 52.3 60.3 84.4 45.6
T 75.8 52.3 61.9 79.1 38.9
S5 D 75.8 59.6 66.7 81.7 57.0
T 71.6 58.3 64.3 76.8 58.0
Sys – Systems; PMD – Protein-Mutation-Disease relationships; PM – Protein-Mutatio
tionships; S1 (System1) – Abstract level co-occurrence; S2 (System2) – Sentence lev
versal; S4 (System4) – Linking two dependency graphs based on entity identity; S5
words.; P – Precision (in %); R – Recall (in %); F – F-measure (in %)the abstract level co-occurrence (S1) achieved the highest
recall S3 achieved the highest precision, and S5 achieved
the best F-measure for almost all the binary relation ex-
traction tasks.
Error analysis
In order to have better understanding of the system per-
formance, we performed manual error analysis on the out-
put of the best system (S5) using the test data set.
Figures 10 and 11 illustrate the percentage distribution of
both the precision and recall errors respectively.
There were 64 precision errors categorized in the
following:
Absence of annotation in UniProtKB
We found nearly 23 (31 %) of the associations extracted
by the system not captured by UniProtKB. For example,
consider the following sentence from an example ab-
stract (PMID - 9973276): “We conclude that the APC
I1307K variant leads to increased adenoma formation
and directly contributes to 3 %-4 % of all Ashkenazi
Jewish colorectal cancer.” The system extracted the tern-
ary relation <APC_HUMAN, Ile, 1307, Lys, 114500 >
from the above sentence. However, in UniProtKB for
“APC_HUMAN” entry the annotation contains only
protein-mutation binary relation (APC_HUMAN and
Lys1307) leaving out the disease colorectal cancer.
Entity detection errors
Errors in entity detection are another significant source
(~22 %) for precision errors. Such errors happen when
there is an overlap in the text span between two entity
classes. Consider the following sentence from an abstract
(PMID - 11565064) “A homozygous R279W mutation
was recently found in the diastrophic dysplasia sulfates
MD PD
F P R F P R F
68.8 61.7 67.7 64.6 67.2 80.6 73.3
68.3 57.0 70.9 63.2 61.1 80.9 69.6
48.1 74.8 44.3 55.6 84.6 59.8 70.0
55.0 67.8 43.6 53.1 74.7 61.4 67.4
59.2 78.2 42.5 55.0 89.3 57.4 69.9
52.2 77.2 41.8 54.3 76.7 59.7 67.2
59.2 78.2 42.5 55.0 89.3 57.4 69.9
52.2 77.2 41.8 54.3 76.7 59.7 67.2
67.2 75.9 60.0 67.0 88.6 63.8 74.2
67.2 74.8 59.3 66.1 76.2 67.7 71.7
n relationships; MD – Mutation-Disease relationships; PD – Protein-disease rela-
el co-occurrence; S3 (System3) – Sentence level dependency graph based tra-
(System5) – Linking two or more graphs based on anaphora resolution/trigger
Fig. 8 Performance trend of systems on development and test data set
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had a club foot and double-layered patella.” MutD cor-
rectly extracted the association among gene DTDST,
mutation R279W, and disease MED. However, the named
entity recognition algorithm failed to recognize “dia-
strophic dysplasia sulfate transporter gene” as a single
entity (gene/protein). Instead, MutD identified “dia-
strophic dysplasia” as a disease and normalized it to
OMIM Id: 222600. This led to the extraction of a false
association between gene DTDST, mutation R279W,
and disease diastrophic dysplasia.Fig. 9 Comparison of performance of systems on test dataEntity normalization errors
Errors in entity normalization contribute significantly
(23.44 %) to precision errors. For example consider the
following sentence from an abstract (PMID: 18678517):
“Thus, the current study identified the DSG2-V55M
polymorphism as a novel risk variant for DCM associ-
ated with shortened desmosomes of the cardiac inter-
calated disc”. Three systems (S3, S4, and S5) gives the
following output <DSG2_HUMAN, Val, 55, Met, 115
200|613424|613642>. The gold standard annotation
for this abstract reads as follows: <DSG2_HUMAN,
Fig. 10 Percentage distribution of precision errors on test data set
Ravikumar et al. BMC Bioinformatics  (2015) 16:185 Page 12 of 15Val, 55, 56, Met, 612877>. While all the fields matched
correctly, none of the three OMIM Ids identified by the
systems matched the one in the gold standard annotation.
Errors in linking dependency graphs through anaphora/
trigger words
Linking dependency graphs through trigger words cause
some of the errors. Consider the following two sentences
from an abstract (PMID-21828135): “Mutational spectrum
analysis of chronic myelomonocytic leukemia includes
genes associated with epigenetic regulation: UTX, EZH2,
and DNMT3A.” and “TET2 mutations were present in
49 %, ASXL1 in 43 %, CBL in 14 %, IDH1/2 in 4 %,
KRAS in 7 %, NRAS in 4 %, and JAK2 V617F in 1 % of
patients”. The trigger word “Mutational” (base form: Mu-
tation) in the first sentence is linked to the point mutation
V617F in the second sentence leading to incorrect associa-






Fig. 11 Percentage distribution of recall errors on test data setchronic myelomonocytic leukemia. Apart from these, de-
pendency parsing also contributed to 3 % of the errors.
Totally, we identified 113 recall errors, detailed in the
following:
Absence of entities in the text
Absence of entities in the text has been the major cause
for the recall errors. Nearly 60 % of the errors are due to
the absence of entity mentions in the abstract. For Uni-
ProtKB entry “APC_HUMAN” the variant “CYS-1395”
is annotated to be involved in “HEPATOBLASTOMA”
where the PMID “8764128” is cited as the literature
evidence. However in the PubMed abstract there is no
mention of any protein point mutation or variant. The
algorithm correctly extracts the protein-disease relation.
In UniProt entry GLCM_HUMAN, four variants (SER-
409, HIS-448, PRO-483 and CYS-502) are annotated to
play a role in Gaucher’s disease with PMID “7627184”rrors
Absence of entities in text
Failure to detect entities in text
Errors in Entity
Errors in Entity Normalization
Parsing errors
Ravikumar et al. BMC Bioinformatics  (2015) 16:185 Page 13 of 15as the literature evidence. After subtracting the length of
signal peptide region (39) from the residue positions, the
modified variants are converted into SER-370, HIS-409,
PRO-444 and CYS-463 respectively. While all the four
modified variants and the disease are mentioned in the
abstract, the protein is not even mentioned anywhere in
the abstract, which results in 4 recall errors. Restricting
our processing to only biomedical abstracts is a primary
reason for this error.
Failure to detect entities
Failure to detect entities is another source for recall
errors. Consider the following sentence from an abstract
(PMID-1972019): “One mutation consists of a single-
base substitution in three different codons: codon 444,
Leu (CTG) to Pro (CCG); codon 456, Ala (GCT) to Pro
(CCT); and codon 460, Val (GTG) to Val (GTC).” Both
PubTator and Mutation-Finder (even with supplemented
patterns) failed to recognize all the three mutation men-
tioned in the sentence resulting in recall errors.
Errors caused by precision errors
There are 41 precision errors also leading to recall errors.
For example consider the following sentence: “Thus, the
current study identified the DSG2-V55M polymorphism
as a novel risk variant for DCM associated with shortened
desmosomes of the cardiac intercalated disc.” In this sen-
tence, the disease “DCM” is not normalized to the OMIM
ID annotated in the gold standard (UniprotKB). Such er-
rors in entity normalization lead to both precision error
and recall error.
The above detailed error analysis indicates 23 of the
64 precision errors are actual associations failed to be
captured by database curators and 68 of the 113 recall
errors are caused by the absence of associated disease en-
tities in the abstract. If we neglect those errors, the ad-
justed precision, recall, and F-measure of S5 in association
detection reach 82.3 %, 80.8 %, and 81.5 % respectively.
Limitations and future directions
In this study, our predominant focus was to address the
linguistic inference challenge from the text for database
curation. We have not paid much attention to the initial
steps (Step 1 and 2) and the expert inference challenge.
Our approach to discourse level analysis is more effect-
ive when the scope of the problem under investigation is
highly targeted like the one in this study. However, we
believe that the issue of an expert inference cannot be
completely addressed by text mining.
In addition, nearly 30-40 % of the gold standard tern-
ary relations were missed by the system due to the ab-
sence of relevant entities in the abstract. One solution is
to extend our system to process full text articles where
we may find mention of more mutation and proteininformation in the text. As a logical next step, we plan
to extend the system to process full text articles. How-
ever, removing the irrelevant associations will be one of
the critical challenges that need to be addressed while
we adapt our text mining approach to extract associa-
tions across sentences from full text articles. Also in
this study, we predominantly focused only on protein
point mutation disease associations. There are other
significant variants at the gene and protein levels such
as deletions and additions, which also play significant
roles in diseases.
Our immediate next plan is to release both the web
and RESTAPI versions of the MutD system. With the in-
creased use of the next generation sequencing in clinical
practice, linking clinical variants to literature mentions
will help clinician interpret the impact of variants and
guide them to take appropriate therapeutic intervention.
We also plan to extend the system to extract drug-
mutation-disease ternary relations from literature, which
can be integrated with other knowledge sources such as
ClinVar [2] may empower physicians to embrace individ-
ualized medicine.
Conclusions
Our study attempts to measure the capability of a text
mining system in automatically extracting database level
annotations from biomedical texts. Our evaluation of
the system against gold standard annotations extracted
from curated database provides insight of the utility of
text mining for database curation. From text mining per-
spective, this is the first attempt to effectively combine
information from multiple sentences to extract ternary
relations between protein, mutation and disease. Our
approach to link dependency graphs across sentences
using entity identity, anaphora and trigger words re-
sulted in substantial performance improvement. Achiev-
ing a performance of 64.3 % of overall F-measure, which
when further revised to 81.5 % after detailed error ana-
lysis demonstrates that our approach to some extent ad-
dressed the linguistic inference challenge faced by the
use of text mining for database curation.
Availability of supporting data
The protein-mutation-disease ternary association and
binary association output for the MutD system for both
the development and test data in BRAT annotation style
is accessible at: http://ohnlp.org/index.php/MutD
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